人工智能增强型心电图对高危情况下无创检测高钾血症的验证。

IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-21 DOI:10.2215/CJN.0000000000000483
David M Harmon, Kan Liu, Jennifer Dugan, Jacob C Jentzer, Zachi I Attia, Paul A Friedman, John J Dillon
{"title":"人工智能增强型心电图对高危情况下无创检测高钾血症的验证。","authors":"David M Harmon, Kan Liu, Jennifer Dugan, Jacob C Jentzer, Zachi I Attia, Paul A Friedman, John J Dillon","doi":"10.2215/CJN.0000000000000483","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) electrocardiogram (ECG) analysis can enable detection of hyperkalemia. In this validation, we assessed the algorithm's performance in two high acuity settings.</p><p><strong>Methods: </strong>An emergency department (ED) cohort (February-August 2021) and a mixed intensive care unit (ICU) cohort (August 2017-February 2018) were identified and analyzed separately. For each group, pairs of laboratory-collected potassium and 12 lead ECGs obtained within four hours of each other were identified. The previously developed AI ECG algorithm was subsequently applied to leads I and II of the 12 lead ECGs to screen for hyperkalemia (potassium > 6.0 mEq/L).</p><p><strong>Results: </strong>The ED cohort (N=40,128) had a mean age of 60 years, 48% were male, and 1% (N=351) had hyperkalemia. The area under the curve (AUC) of the AI-ECG to detect hyperkalemia was 0.88, with sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of, 80%, 80%, 3%, 99.8% and 4.0, respectively, in the ED cohort. Low-eGFR (<30 ml/min) subanalysis yielded AUC, sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 0.83, 86%, 60%, 15%, 98% and 2.2, respectively, in the ED cohort. The ICU cohort (N=2,636) had a mean age of 65 years, 60% were male, and 3% (N=87) had hyperkalemia. The AUC for the AI-ECG was 0.88 and yielded sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 82%, 82%, 14%, 99% and 4.6, respectively in the ICU cohort. Low-eGFR subanalysis yielded AUC, sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 0.85, 88%, 67%, 29%, 97% and 2.7, respectively in the ICU cohort.</p><p><strong>Conclusion: </strong>The AI-ECG algorithm demonstrated a high negative predictive value, suggesting that it is useful for ruling out hyperkalemia, but a low positive predictive value, suggesting that it is insufficient for treating hyperkalemia.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5000,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Validation of Non-invasive Detection of Hyperkalemia by Artificial Intelligence Enhanced Electrocardiography in High Acuity Settings.\",\"authors\":\"David M Harmon, Kan Liu, Jennifer Dugan, Jacob C Jentzer, Zachi I Attia, Paul A Friedman, John J Dillon\",\"doi\":\"10.2215/CJN.0000000000000483\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Artificial intelligence (AI) electrocardiogram (ECG) analysis can enable detection of hyperkalemia. In this validation, we assessed the algorithm's performance in two high acuity settings.</p><p><strong>Methods: </strong>An emergency department (ED) cohort (February-August 2021) and a mixed intensive care unit (ICU) cohort (August 2017-February 2018) were identified and analyzed separately. For each group, pairs of laboratory-collected potassium and 12 lead ECGs obtained within four hours of each other were identified. The previously developed AI ECG algorithm was subsequently applied to leads I and II of the 12 lead ECGs to screen for hyperkalemia (potassium > 6.0 mEq/L).</p><p><strong>Results: </strong>The ED cohort (N=40,128) had a mean age of 60 years, 48% were male, and 1% (N=351) had hyperkalemia. The area under the curve (AUC) of the AI-ECG to detect hyperkalemia was 0.88, with sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of, 80%, 80%, 3%, 99.8% and 4.0, respectively, in the ED cohort. Low-eGFR (<30 ml/min) subanalysis yielded AUC, sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 0.83, 86%, 60%, 15%, 98% and 2.2, respectively, in the ED cohort. The ICU cohort (N=2,636) had a mean age of 65 years, 60% were male, and 3% (N=87) had hyperkalemia. The AUC for the AI-ECG was 0.88 and yielded sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 82%, 82%, 14%, 99% and 4.6, respectively in the ICU cohort. Low-eGFR subanalysis yielded AUC, sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 0.85, 88%, 67%, 29%, 97% and 2.7, respectively in the ICU cohort.</p><p><strong>Conclusion: </strong>The AI-ECG algorithm demonstrated a high negative predictive value, suggesting that it is useful for ruling out hyperkalemia, but a low positive predictive value, suggesting that it is insufficient for treating hyperkalemia.</p>\",\"PeriodicalId\":50681,\"journal\":{\"name\":\"Clinical Journal of the American Society of Nephrology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2024-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Journal of the American Society of Nephrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2215/CJN.0000000000000483\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Journal of the American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2215/CJN.0000000000000483","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:人工智能(AI)心电图(ECG)分析可以检测高钾血症。在此次验证中,我们评估了该算法在两种高危情况下的性能:确定并分别分析了急诊科(ED)队列(2021 年 2 月至 8 月)和重症监护室(ICU)混合队列(2017 年 8 月至 2018 年 2 月)。每组都确定了实验室收集的钾和 12 导联心电图对,这两组心电图是在四小时内获得的。随后将先前开发的人工智能心电图算法应用于 12 导联心电图的 I 和 II 导联,以筛查高钾血症(血钾 > 6.0 mEq/L):急诊室队列(N=40,128)的平均年龄为 60 岁,48% 为男性,1%(N=351)患有高钾血症。在急诊室队列中,AI-ECG 检测高钾血症的曲线下面积(AUC)为 0.88,灵敏度、特异性、阳性预测值、阴性预测值和阳性似然比分别为 80%、80%、3%、99.8% 和 4.0。低表皮生长因子受体(结论:AI-ECG 算法显示出较高的阴性预测值,表明它有助于排除高钾血症,但阳性预测值较低,表明它不足以治疗高钾血症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Validation of Non-invasive Detection of Hyperkalemia by Artificial Intelligence Enhanced Electrocardiography in High Acuity Settings.

Background: Artificial intelligence (AI) electrocardiogram (ECG) analysis can enable detection of hyperkalemia. In this validation, we assessed the algorithm's performance in two high acuity settings.

Methods: An emergency department (ED) cohort (February-August 2021) and a mixed intensive care unit (ICU) cohort (August 2017-February 2018) were identified and analyzed separately. For each group, pairs of laboratory-collected potassium and 12 lead ECGs obtained within four hours of each other were identified. The previously developed AI ECG algorithm was subsequently applied to leads I and II of the 12 lead ECGs to screen for hyperkalemia (potassium > 6.0 mEq/L).

Results: The ED cohort (N=40,128) had a mean age of 60 years, 48% were male, and 1% (N=351) had hyperkalemia. The area under the curve (AUC) of the AI-ECG to detect hyperkalemia was 0.88, with sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of, 80%, 80%, 3%, 99.8% and 4.0, respectively, in the ED cohort. Low-eGFR (<30 ml/min) subanalysis yielded AUC, sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 0.83, 86%, 60%, 15%, 98% and 2.2, respectively, in the ED cohort. The ICU cohort (N=2,636) had a mean age of 65 years, 60% were male, and 3% (N=87) had hyperkalemia. The AUC for the AI-ECG was 0.88 and yielded sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 82%, 82%, 14%, 99% and 4.6, respectively in the ICU cohort. Low-eGFR subanalysis yielded AUC, sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio of 0.85, 88%, 67%, 29%, 97% and 2.7, respectively in the ICU cohort.

Conclusion: The AI-ECG algorithm demonstrated a high negative predictive value, suggesting that it is useful for ruling out hyperkalemia, but a low positive predictive value, suggesting that it is insufficient for treating hyperkalemia.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
12.20
自引率
3.10%
发文量
514
审稿时长
3-6 weeks
期刊介绍: The Clinical Journal of the American Society of Nephrology strives to establish itself as the foremost authority in communicating and influencing advances in clinical nephrology by (1) swiftly and effectively disseminating pivotal developments in clinical and translational research in nephrology, encompassing innovations in research methods and care delivery; (2) providing context for these advances in relation to future research directions and patient care; and (3) becoming a key voice on issues with potential implications for the clinical practice of nephrology, particularly within the United States. Original manuscript topics cover a range of areas, including Acid/Base and Electrolyte Disorders, Acute Kidney Injury and ICU Nephrology, Chronic Kidney Disease, Clinical Nephrology, Cystic Kidney Disease, Diabetes and the Kidney, Genetics, Geriatric and Palliative Nephrology, Glomerular and Tubulointerstitial Diseases, Hypertension, Maintenance Dialysis, Mineral Metabolism, Nephrolithiasis, and Transplantation.
期刊最新文献
Bisphosphonate Use After Kidney Transplantation Is Associated with Lower Fracture Risk. Surrogate Endpoints in APOL1-Associated Kidney Disease: Evaluation in Three Cohorts. From Home to Wearable Hemodialysis: Barriers, Progress, and Opportunities. Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease. Exercise and Cognitive Function in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Efficacy and Harms.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1